GST for Pharma Distributors & Chemists in Ajmer — GST 2.0 Rates, ITC & Full Compliance

Rajasthan's spiritual heart — Ajmer is home to the revered Dargah of Khwaja Moinuddin Chishti, the sacred Pushkar lake, and is a major marble and granite trading hub. The pharmaceutical sector in Ajmer, Rajasthan — whether you are a manufacturer, CFA (Carrying and Forwarding Agent), super-stockist, distributor, sub-stockist, or retail chemist — operates under one of the most complex GST environments in India. The landmark GST 2.0 rationalisation effective 22 September 2025 has significantly changed tax rates across the pharma supply chain, creating immediate compliance challenges around stock transition, ITC adjustment, and correct billing. Add to this the persistent inverted duty structure issue (APIs at 18%, finished medicines at 5%), mandatory ITC reversal on expired stock and free samples, and the expanding e-invoicing mandate — and you have a compliance landscape that demands expert CA oversight. TaxAMC's CA team provides dedicated GST management for the complete pharmaceutical supply chain across Ajmer.

1. GST 2.0 (22 September 2025) — What Changed for Pharma Businesses in Ajmer

The 56th GST Council meeting (September 2025) announced the most significant rationalisation of pharma GST rates since GST's introduction in 2017. The changes took effect from 22 September 2025. Key impacts on Ajmer pharma businesses:

• 37 specified life-saving drugs: 0% GST (Nil) — previously 12%. Includes drugs for rare diseases, oncology, enzyme replacement therapies (gene therapy, Asciminib, Mepolizumab, Daratumumab, Entrectinib, Atezolizumab, Spesolimab, and 30 others). Full list in CBIC Notification No. 9/2025-CT (Rate).
• Most finished medicines under Chapter 30: 5% GST — reduced from the earlier 12%. This is the most sweeping change — covering the vast majority of prescription medicines, formulations, and OTC drugs previously in the 12% slab.
• Medical devices and diagnostic equipment: 5% GST — significantly reduced from 18% and 12%. Surgical instruments, diagnostic equipment, patient monitoring devices, and hospital equipment now attract 5%.
• Health insurance premiums: GST-free (Nil) — previously 18% GST was levied on health insurance premiums, making coverage expensive. GST 2.0 made health insurance completely GST-exempt.
• Unchanged — APIs, KSMs, chemical intermediates: 18% GST — the critical inputs for medicine manufacturing remain at 18%, perpetuating the inverted duty structure challenge for pharma manufacturers.
• Unchanged — Vitamins, nutraceuticals, and OTC supplements: 18% GST — not part of the rationalisation.

2. Current GST Rate Table — Medicines, Devices & Pharma Products (Post Sept 2025)

Category	HSN Chapter	GST Rate (Post 22 Sept 2025)	Previous Rate	ITC Available?
37 specified life-saving drugs (rare diseases, critical oncology, enzyme replacement)	Chapter 30	0% (Nil)	12%	❌ No ITC on inputs used for Nil-rated output
Most prescription medicines & formulations	Chapter 30 (HSN 3004)	5%	12%	✅ ITC allowed on taxable inputs
Vaccines (hepatitis, rabies, typhoid, etc.)	HSN 3002	5%	5%	✅ ITC allowed
Oral rehydration salts, contraceptives (condoms, OCPs)	Chapter 30	Nil/Exempt	Nil	❌ No ITC for Nil-rated
Active Pharmaceutical Ingredients (APIs), KSMs, chemical intermediates	Various — Chapters 28, 29	18%	18%	✅ Full ITC — but accumulates due to inverted duty
Medical devices — diagnostic, surgical, patient monitoring	Chapter 90	5%	12–18%	✅ ITC allowed
Surgical instruments, stents, implants	Chapter 90	5%	5–12%	✅ ITC allowed
Disposables — syringes, gloves, IV bags, gauze	Chapter 90/39	5–12%	5–12%	✅ ITC allowed
Vitamins, nutraceuticals, health supplements	Chapter 21/23/30	18%	18%	✅ ITC allowed
Ayurvedic / herbal medicines — branded	Chapter 30	5–12%	5–12%	✅ ITC allowed on taxable items
Hospital room rent (non-ICU) >₹5,000/day	Services	5% (no ITC)	5% (since July 2022)	❌ Blocked — no ITC
Health insurance premiums	Services	Nil (GST-free)	18%	N/A — Nil-rated service
ICU/CCU/NICU room charges	Services	Nil (fully exempt)	Nil	N/A

3. Documents Required for Pharma GST Registration & Ongoing Compliance in Ajmer

4. ITC Management for Pharma Businesses in Ajmer — What Can and Cannot Be Claimed

Input/Expense	ITC Claimable?	Conditions
Medicines purchased for resale (now at 5%)	✅ Yes — 5% ITC	Must appear in GSTR-2B. Invoice must show correct HSN and rate.
APIs purchased for manufacturing (at 18%)	✅ Yes — 18% ITC	Accumulates due to inverted duty — refund claim needed.
Medical devices purchased for resale (now at 5%)	✅ Yes — 5% ITC	Must appear in GSTR-2B with correct HSN.
Packaging materials (cartons, labels, strips)	✅ Yes — ITC at applicable rate	Must be from GST-registered suppliers with proper invoices.
Cold chain and refrigeration equipment	✅ Yes — ITC allowed	For storage of taxable medicines — full ITC available.
Warehouse rent (for taxable medicines)	✅ Yes — 18% GST on rent	ITC available if used for taxable supply chain.
Free samples distributed to doctors	❌ No — ITC must be REVERSED	Section 17(5)(h) — ITC on sample purchase must be reversed at time of distribution.
Expired medicines — destroyed or written off	❌ No — ITC must be REVERSED	Section 17(5)(h) — ITC reversed in the GSTR-3B of the month of destruction.
Inputs used for Nil-rated medicines (37 life-saving drugs)	❌ No ITC for Nil-rated supplies	Proportionate ITC reversal required under Rule 42/43 if you supply both taxable and Nil-rated medicines.
Personal vehicle (car) used for delivery	❌ Blocked under Section 17(5)	Motor vehicles for <13-person passenger transport — ITC always blocked.
Doctor visit expenses, gifts to doctors	❌ Blocked — Section 17(5)(h)	Any gifts or freebies to doctors — ITC on these inputs blocked. Also Section 194R TDS applicability.

5. Expired Stock, Free Samples & Destroyed Goods — Mandatory ITC Reversal in Ajmer

This is the highest-risk area for GST notices in the pharma sector. Many Ajmer distributors and chemists are unaware that ITC already claimed on purchased medicines must be reversed when those medicines are later destroyed or distributed free.

Section 17(5)(h) — The Blocked ITC Rule for Pharma:
"Input tax credit shall not be available in respect of goods lost, stolen, destroyed, written off or disposed of by way of gift or free samples."

Practical situations requiring ITC reversal for Ajmer pharma businesses:

Situation	When to Reverse	Amount to Reverse	How to Report
Expired medicines — destroyed	In the GSTR-3B of the month in which the expired stock is destroyed	ITC originally claimed on the purchase of the expired batch	Report in GSTR-3B Table 4(B) — Ineligible ITC
Free samples to doctors	In the GSTR-3B of the month in which samples are distributed	5% GST (ITC) on the purchase value of samples distributed	Reduce ITC in GSTR-3B; maintain sample distribution register as proof
Breakage and transit damage	In the month of written-off entry in books	Proportionate ITC on damaged goods	Table 4(B) of GSTR-3B
Theft or pilferage	In the month of discovery / FIR filing	ITC on stolen goods — full reversal	Table 4(B) of GSTR-3B
Near-expiry stock sold below cost / destroyed	Month of destruction	ITC on goods destroyed (not on goods sold — even at loss)	Table 4(B) of GSTR-3B

6. Inverted Duty Structure — Refund Claims for Ajmer Pharma Businesses

The inverted duty structure (IDS) in pharma arises when the GST rate on inputs (APIs at 18%) is higher than the GST rate on the final output (finished medicines at 5%). This means ITC accumulates faster than it can be utilised — creating a permanent working capital blockage.

Who faces IDS in the Ajmer pharma supply chain:

• Pharmaceutical manufacturers — buy APIs at 18% GST, sell finished medicines at 5%. Maximum IDS impact — significant ITC accumulation.
• Nutraceutical manufacturers — buy ingredients at 12–18%, sell at 18% (some OTC items). IDS may exist for specific input mixes.
• Medical device manufacturers — now reduced to 5% output rate; input components at higher rates — IDS may arise for specific categories.
• Distributors/stockists — typically buy and sell at the same rate, so IDS is less common. However, if you stock any Nil-rated items (37 life-saving drugs), proportionate ITC reversal is required.

IDS Refund under Section 54(3) of CGST Act:

• Eligible manufacturers can claim refund of accumulated ITC that cannot be set off against output tax — up to 90% as provisional refund
• Refund application filed in Form GST RFD-01 on the GST portal
• Supporting documents: Purchase invoices for inputs, sales invoices for output, GSTR-2B, financial statements, CA certificate certifying ITC accumulation due to inverted duty
• Refund is processed within 60 days of application — subject to verification
• Planning point: Imported inputs (APIs) attract IGST at 18% on BoE filing date — if BoE filed before 22 Sept 2025, old IGST rate applies; if filed on/after 22 Sept 2025, new rate applies

7. E-Invoicing for Pharma Businesses in Ajmer — Mandatory Thresholds

E-invoicing is now a critical compliance requirement for larger pharma businesses. Here are the latest mandatory thresholds:

Annual Aggregate Turnover (AATO)	E-Invoicing Mandatory?	Time Limit to Upload to IRP	Effective Date
Above ₹5 crore	✅ Yes — all B2B invoices, exports, credit/debit notes	No fixed window (upload before filing GSTR-1)	Since 1 August 2023
Above ₹10 crore	✅ Yes — same as above	Within 30 days of invoice date — invoice rejected by IRP after 30 days	Since 1 April 2025
Below ₹5 crore	❌ Not mandatory yet	N/A — voluntary e-invoicing possible	Future expansion expected

What e-invoicing means for Ajmer pharma businesses in practice:

• Every B2B invoice (to a GST-registered buyer) must be uploaded to the Invoice Registration Portal (IRP) before it is sent to the buyer
• The IRP generates an Invoice Reference Number (IRN) and a QR code — both must be printed on the invoice
• Without IRN + QR code, the buyer cannot claim ITC on your invoice — this damages your customer relationships in the pharma supply chain
• If your AATO is above ₹10 crore, invoices dated more than 30 days ago will be rejected by the IRP — making them invalid for ITC
• 2FA (Two-Factor Authentication) is mandatory from 1 April 2025 for all taxpayers for e-invoice and e-way bill generation on the GST portal
• B2C invoices (retail pharmacy sales to individual patients) are not currently subject to e-invoicing for pharma businesses — but must follow normal invoice format

8. Monthly GST Return Filing for Ajmer Pharma Businesses

Return	What It Contains	Due Date	Pharma-Specific Notes
GSTR-1	All outward sales invoices — B2B (hospital/distributor) and B2C (retail pharmacy)	11th of following month	HSN-wise summary mandatory. Correct new 5% rate for medicines post-Sept 2025. B2B invoices include buyer's GSTIN for ITC chain. Export invoices (if any) shown separately.
GSTR-3B	Summary — total sales, ITC claimed, ITC reversed (expired stock, samples), net tax payment	20th of following month	ITC reversal for expired stock and free samples done in Table 4(B). Correct bifurcation of 5% and 18% ITC. Inverted duty ITC accumulation tracked for refund eligibility.
GSTR-9	Annual reconciliation of all transactions	31st December of following FY	Mandatory if AATO above ₹2 crore. Critical for pharma — annual reconciliation of expired stock, free samples, and rate transitions often reveals discrepancies.
GSTR-9C	Self-certified reconciliation statement	31st December of following FY	Mandatory if AATO above ₹5 crore. Requires audited financial reconciliation by CA.

9. Common GST Errors That Get Ajmer Pharma Businesses Notices

1. Billing medicines at old 12% GST rate after 22 September 2025 — the new 5% rate must be applied from that date. Invoices at 12% post-Sept 2025 are incorrect and attract ITC reversal demands from buyers.
2. Not reversing ITC on expired medicines — the single most common GST notice trigger in pharma. Must be done in the month of destruction, with a destruction certificate as evidence.
3. Not reversing ITC on free samples to doctors — Section 17(5)(h) explicitly blocks this ITC. Pharma companies often claim ITC on samples, which is incorrect.
4. Incorrect HSN code on invoices — especially for combination products, nutraceuticals, and devices that straddle multiple chapters. Wrong HSN leads to wrong rate, GST department notices, and buyer ITC disputes.
5. Not bifurcating Nil-rated (37 drugs) from taxable supplies in GSTR-1 — Nil-rated supplies must be reported separately. Proportionate ITC reversal is required for inputs used in Nil-rated medicine production.
6. Claiming ITC on inputs used for exempt/Nil medicines without Rule 42/43 reversal — if you stock both taxable (5%) and Nil-rated medicines, ITC must be apportioned. Failure to do so attracts demand for the entire un-reversed ITC amount with 18% interest.
7. Missing e-invoicing for B2B transactions above ₹5 crore AATO — buyers cannot claim ITC on invoices without IRN. If your buyer is a hospital or another distributor, missing e-invoicing damages the supply chain ITC and triggers customer complaints and GST notices.
8. Missing 30-day IRP upload deadline (for AATO above ₹10 crore) — from 1 April 2025, any B2B invoice older than 30 days is rejected by the IRP. The invoice becomes invalid for ITC — a major issue for large pharma distributors in Ajmer.

10. Areas We Serve in Ajmer

TaxAMC provides services across all localities in Ajmer, including:

• Ramganj Mandi
• Pushkar Road
• RIICO Industrial Area
• Vaishali Nagar
• Nasirabad Cantonment

Also serving nearby cities: Jaipur, Tonk, Nagaur, Pali.

11. Frequently Asked Questions — Pharma GST in Ajmer

Q: What GST rate do I apply on medicines from 22 September 2025 in Ajmer?
Most finished medicines and formulations: 5% (down from 12%). 37 life-saving drugs: 0% (Nil). APIs and KSMs: 18% (unchanged). Medical devices: 5% (down from 18%). Vitamins and nutraceuticals: 18%. TaxAMC provides SKU-wise rate updates for your specific product range.

Q: Do I need to issue credit notes for invoices raised at 12% before 22 September 2025?
No — invoices raised at 12% before the effective date were correct at that time. Only invoices raised on or after 22 September 2025 at the old 12% rate need correction. TaxAMC identifies and corrects any such errors.

Q: My pharmacy in Ajmer has expired stock — what do I do about ITC?
Reverse the ITC originally claimed on those batches in the GSTR-3B of the month in which the stock is destroyed. Maintain a destruction certificate. TaxAMC calculates the exact reversal amount and files it correctly.

Q: I distribute free samples to doctors in Ajmer — is the ITC on sample purchases reversible?
Yes — mandatory reversal under Section 17(5)(h). The ITC on medicines distributed as free samples must be reversed in the GSTR-3B of the month of distribution. Also note Section 194R TDS applicability if sample value to a doctor exceeds ₹20,000/year.

Q: My pharma distribution turnover is ₹8 crore — do I need e-invoicing?
Yes — e-invoicing is mandatory for all AATO above ₹5 crore since August 2023. All your B2B invoices to hospitals, clinics, and other distributors must have IRN and QR code. The 30-day upload deadline applies from ₹10 crore AATO — at ₹8 crore you have flexibility on timing but must upload before filing GSTR-1.